Catestanin - a promising biological marker for heart failure: A review
The epidemic of heart failure (HF) is one of the problems that the global health system has been facing for decades. HF is a multicomponent clinical syndrome caused by dysfunction of the heart and its pathological remodeling. In addition to the well-known natriuretic peptides, a number of cardiovasc...
Saved in:
Main Authors: | Amina M. Alieva (Author), Natalia V. Teplova (Author), Elena V. Reznik (Author), Olga A. Ettinger (Author), Rashad A. Faradzhov (Author), Elvira A. Khachirova (Author), Irina V. Kovtiukh (Author), Irina A. Kotikova (Author), Diana A. Sysoeva (Author), Il'dar R. Bigushev (Author), Igor G. Nikitin (Author) |
---|---|
Format: | Book |
Published: |
ZAO "Consilium Medicum",
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fibroblast growth factor 21 (FGF21): diagnostic, prognostic and therapeutic aspects in heart failure. A review
by: Amina M. Alieva, et al.
Published: (2024) -
LOX-1 as a biological marker and therapeutic target in cardiovascular pathology (literature review)
by: Amina M. Alieva, et al.
Published: (2024) -
Endocan is a key player in cardiovascular disease: A review
by: Amina M. Alieva, et al.
Published: (2023) -
Pentraxin-3 - a promising biological marker in heart failure: literature review
by: Amina M. Alieva, et al.
Published: (2022) -
The role of interleukin-6 in the development of cardiovascular diseases: A review
by: Amina M. Alieva, et al.
Published: (2023)